carbapenems has been researched along with ceftobiprole in 8 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (ceftobiprole) | Trials (ceftobiprole) | Recent Studies (post-2010) (ceftobiprole) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 212 | 15 | 97 |
| Protein | Taxonomy | carbapenems (IC50) | ceftobiprole (IC50) |
|---|---|---|---|
| MecA | Staphylococcus aureus | 4.1667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalziel, C; Turner, B | 1 |
| French, GL | 1 |
| Micek, ST; Neuner, EA; Ritchie, DJ | 1 |
| Cattoir, V; Daurel, C | 1 |
| Elborn, JS; Parkins, MD | 1 |
| De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA | 1 |
| Anbarasu, A; Kumar, KM; Ramaiah, S | 1 |
| Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lam, C; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
4 review(s) available for carbapenems and ceftobiprole
| Article | Year |
|---|---|
What's new and not so new on the antimicrobial horizon?
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Pyrimidines; Research | 2008 |
New antibiotics for healthcare-associated pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin | 2009 |
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline | 2010 |
4 other study(ies) available for carbapenems and ceftobiprole
| Article | Year |
|---|---|
Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. Release of data for Dc-159a, and other agents. 27-30 September 2006, San Francisco, CA, USA.
Topics: Animals; Anti-Infective Agents; Carbapenems; Cephalosporins; Drugs, Investigational; Estrogen Receptor Modulators; Fluoroquinolones; Humans; Naphthols; Societies, Scientific; United States | 2006 |
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic | 2012 |
Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Escherichia coli; Molecular Docking Simulation; Molecular Dynamics Simulation; Penicillin-Binding Proteins; Peptide Synthases; Protein Binding; Staphylococcus aureus; Streptococcus pneumoniae | 2014 |
Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Surveys and Questionnaires; Taiwan | 2016 |